CGC

Canopy Growth Corporation ( WEED:CA ) Q2 2027 Earnings Call November 6, 2026 10:00 AM EST Company Participants John Vincic Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Kenric Tyghe - Canaccord Genuity Corp., Research Division Frederico Yokota Gomes - ATB Cormark Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning. My name is Joanna, and I will be your conference operator today.

Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve positive adjusted EBITDA in the second half of fiscal 2027.

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.01 per share a year ago.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “We have made tremendous progress on our international strategy. Our internati.

Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”). A total of 154,837,897 common shares of the Company (the “Shares”), representing 36.60% of.

Canopy Growth NASDAQ: CGC shareholders approved all matters presented at the company's reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election of five directors and the appointment of MNP LLP as auditor for fiscal 2027.

Despite last December's Executive Order, efforts to reschedule marijuana remained stymied by bureaucratic gridlock. Canopy Growth shares have tumbled on this regulatory inaction, but that's not the largest issue at hand for the company.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.